All Stories

  1. Cannabinol Interactions With the Melatonergic Pathway

    Article • Basic & Clinical Pharmacology & Toxicology, March 2025, Wiley

    George Anderson

  2. Cannabinol interactions with the melatonergic pathway

    Article • January 2025, Wiley

    George Anderson

  3. Physiological processes underpinning the ubiquitous benefits and interactions of melatonin, butyrate and green tea in neurodegenerative conditions

    Article • Melatonin Research, April 2024, ST Bio-life

    George Anderson

  4. Polycystic Ovary Syndrome Pathophysiology: Integrating Systemic, CNS and Circadian Processes

    Article • Frontiers in Bioscience-Landmark, January 2024, IMR Press

    George Anderson

  5. A More Holistic Perspective of Alzheimer's Disease: Roles of Gut Microbiome, Adipocytes, HPA Axis, Melatonergic Pathway and Astrocyte Mitochondria in the Emergence of Autoimmunity

    Article • Frontiers in Bioscience-Landmark, December 2023, IMR Press

    George Anderson

  6. Role of the Night-Time Systemic Processes and the Astrocyte Tryptophan-Melatonin Pathway in the Regulation of α-Synuclein and Wider Parkinson’s Disease Pathophysiology

    Article • November 2023, MDPI AG

    George Anderson

  7. Gut Microbiome and Circadian Interactions with Platelets Across Human Diseases, including Alzheimer’s Disease, Amyotrophic Lateral Sclerosis, and Cancer

    Article • Current Topics in Medicinal Chemistry, November 2023, Bentham Science Publishers

    George Anderson

  8. Melatonin, BAG-1 and cortisol circadian interactions in tumor pathogenesis and patterned immune responses

    Article • Exploration of Targeted Anti-tumor Therapy, October 2023, Open Exploration Publishing

    George Anderson

  9. Melatonin modulates tumor metabolism and mitigates metastasis

    Article • Expert Review of Endocrinology & Metabolism, July 2023, Taylor & Francis

    George Anderson

  10. Redefining Autoimmune Disorders’ Pathoetiology: Implications for Mood and Psychotic Disorders’ Association with Neurodegenerative and Classical Autoimmune Disorders

    Article • Cells, April 2023, MDPI AG

    George Anderson

  11. Type I Diabetes Pathoetiology and Pathophysiology: Roles of the Gut Microbiome, Pancreatic Cellular Interactions, and the ‘Bystander’ Activation of Memory CD8+ T Cells

    Article • International Journal of Molecular Sciences, February 2023, MDPI AG

    George Anderson

  12. Why do anti-amyloid beta antibodies not work? Time to reconceptualize dementia pathophysiology by incorporating astrocyte melatonergic pathway desynchronization from amyloid-beta production

    Article • Brazilian Journal of Psychiatry, January 2023, FRACTAL EDITORA LTDA

    George Anderson

  13. Amyotrophic Lateral Sclerosis Pathoetiology and Pathophysiology: Roles of Astrocytes, Gut Microbiome, and Muscle Interactions via the Mitochondrial Melatonergic Pathway, with Disruption by Glyphosate-Based Herbicides

    Article • International Journal of Molecular Sciences, December 2022, MDPI AG

    George Anderson

  14. Depression Pathophysiology: Astrocyte Mitochondrial Melatonergic Pathway as Crucial Hub

    Article • International Journal of Molecular Sciences, December 2022, MDPI AG

    George Anderson

  15. Tumor Microenvironment and Metabolism: Role of the Mitochondrial Melatonergic Pathway in Determining Intercellular Interactions in a New Dynamic Homeostasis

    Article • International Journal of Molecular Sciences, December 2022, MDPI AG

    George Anderson

  16. Clozapine and the aryl hydrocarbon receptor

    Article • Journal of Psychopharmacology, April 2022, SAGE Publications

    George Anderson

  17. Mitochondrial N-methyl-d-aspartate receptor activation enhances bioenergetics by calcium-dependent and –Independent mechanisms

    Article • Mitochondrion, July 2021, Elsevier

    George Anderson

  18. False Dogmas in Schizophrenia Research: Toward the Reification of Pathway Phenotypes and Pathway Classes

    Article • Frontiers in Psychiatry, June 2021, Frontiers

    George Anderson

  19. Melatonin, Its Beneficial Effects on Embryogenesis from Mitigating Oxidative Stress to Regulating Gene Expression

    Article • International Journal of Molecular Sciences, May 2021, MDPI AG

    George Anderson

  20. The melatonergic pathway and its interactions in modulating respiratory system disorders

    Article • Biomedicine & Pharmacotherapy, May 2021, Elsevier

    George Anderson

  21. Tryptophan Metabolites and Aryl Hydrocarbon Receptor in Severe Acute Respiratory Syndrome, Coronavirus-2 (SARS-CoV-2) Pathophysiology

    Article • International Journal of Molecular Sciences, February 2021, MDPI AG

    George Anderson

  22. Disrupted nocturnal melatonin in autism: Association with tumor necrosis factor and sleep disturbances

    Article • Journal of Pineal Research, January 2021, Wiley

    Professor Regina P Markus, George Anderson

  23. Sirtuins, mitochondria, and the melatonergic pathway in Alzheimer’s disease

    Article • January 2021, Elsevier

    George Anderson

  24. Tumour Microenvironment: Roles of the Aryl Hydrocarbon Receptor, O-GlcNAcylation, Acetyl-CoA and Melatonergic Pathway in Regulating Dynamic Metabolic Interactions across Cell Types—Tumour Microenvironment and Metabolism

    Article • International Journal of Molecular Sciences, December 2020, MDPI AG

    George Anderson

  25. Role of Opioidergic System in Regulating Depression Pathophysiology

    Article • Current Pharmaceutical Design, December 2020, Bentham Science Publishers

    George Anderson

  26. Mitochondria and immunity in chronic fatigue syndrome

    Article • Progress in Neuro-Psychopharmacology and Biological Psychiatry, December 2020, Elsevier

    George Anderson

  27. Inflammation and Mitochondrial Dysfunction in Autism Spectrum Disorder

    Article • CNS & Neurological Disorders - Drug Targets, November 2020, Bentham Science Publishers

    George Anderson

  28. Chronic fatigue and depression due to multiple sclerosis: Immune-inflammatory pathways, tryptophan catabolites and the gut-brain axis as possible shared pathways

    Article • Multiple Sclerosis and Related Disorders, November 2020, Elsevier

    George Anderson

  29. Preventive treatments to slow substantia nigra damage and Parkinson’s disease progression: A critical perspective review

    Article • Pharmacological Research, November 2020, Elsevier

    George Anderson

  30. Aryl Hydrocarbon Receptor Role in Co-Ordinating SARS-CoV-2 Entry and Symptomatology: Linking Cytotoxicity Changes in COVID-19 and Cancers; Modulation by Racial Discrimination Stress

    Article • Biology, August 2020, MDPI AG

    George Anderson

  31. Melatonin and cocaine: role of mitochondria, immunity, and gut microbiome

    Article • Brazilian Journal of Psychiatry, August 2020, FRACTAL EDITORA LTDA

    George Anderson

  32. COVID-19 pathophysiology: interactions of gut microbiome, melatonin, vitamin D, stress, kynurenine and the alpha 7 nicotinic receptor: Treatment implications

    Article • Melatonin Research, June 2020, ST Bio-life

    George Anderson

  33. Gut Dysbiosis Dysregulates Central and Systemic Homeostasis via Suboptimal Mitochondrial Function: Assessment, Treatment and Classification Implications

    Article • Current Topics in Medicinal Chemistry, April 2020, Bentham Science Publishers

    George Anderson

  34. Melatonin: Roles in influenza, Covid‐19, and other viral infections

    Article • Reviews in Medical Virology, April 2020, Wiley

    George Anderson

  35. The Role of Prenatal Melatonin in the Regulation of Childhood Obesity

    Article • Biology, April 2020, MDPI AG

    George Anderson

  36. Pathoetiology and pathophysiology of borderline personality: Role of prenatal factors, gut microbiome, mu- and kappa-opioid receptors in amygdala-PFC interactions

    Article • Progress in Neuro-Psychopharmacology and Biological Psychiatry, March 2020, Elsevier

    George Anderson

  37. The effects of melatonin on signaling pathways and molecules involved in glioma

    Article • Fundamental and Clinical Pharmacology, February 2020, Wiley

    George Anderson

  38. Integrating Autism Spectrum Disorder Pathophysiology: Mitochondria, Vitamin A, CD38, Oxytocin, Serotonin and Melatonergic Alterations in the Placenta and Gut

    Article • Current Pharmaceutical Design, January 2020, Bentham Science Publishers

    George Anderson

  39. Autism Spectrum Disorders: Role of Pre- and Post-Natal GammaDelta (γδ) T Cells and Immune Regulation

    Article • Current Pharmaceutical Design, January 2020, Bentham Science Publishers

    George Anderson

  40. Gut-Amygdala Interactions in Autism Spectrum Disorders: Developmental Roles via regulating Mitochondria, Exosomes, Immunity and microRNAs

    Article • Current Pharmaceutical Design, January 2020, Bentham Science Publishers

    George Anderson

  41. Autism Spectrum Disorder: Pathophysiology and Treatment Implications

    Article • Current Pharmaceutical Design, January 2020, Bentham Science Publishers

    George Anderson

  42. Early and very early‐onset schizophrenia compared with adult‐onset schizophrenia: French FACE‐SZ database

    Article • Brain and Behavior, January 2020, Wiley

    George Anderson

  43. Glioblastoma chemoresistance: roles of the mitochondrial melatonergic pathway

    Article • January 2020, OAE Publishing

    George Anderson

  44. The gut microbiome integrates immune-inflammatory processes in depression

    Article • Dusunen Adam The Journal of Psychiatry and Neurological Sciences, January 2020, Kare Publishing

    George Anderson

  45. Daytime orexin and night-time melatonin regulation of mitochondria melatonin: roles in circadian oscillations systemically and centrally in breast cancer symptomatology

    Article • Melatonin Research, December 2019, ST Bio-life

    George Anderson

  46. Integrating Pathophysiology in Migraine: Role of the Gut Microbiome and Melatonin

    Article • Current Pharmaceutical Design, November 2019, Bentham Science Publishers

    George Anderson

  47. Multiple Sclerosis: Melatonin, Orexin, and Ceramide Interact with Platelet Activation Coagulation Factors and Gut-Microbiome-Derived Butyrate in the Circadian Dysregulation of Mitochondria in Glia and Immune Cells

    Article • International Journal of Molecular Sciences, November 2019, MDPI AG

    George Anderson

  48. The regulation of melatonin production within mitochondria reframes the nature of breast cancers

    Article • Biochemical Pharmacology, October 2019, Elsevier

    George Anderson

  49. The Role of Aberrations in the Immune-Inflammatory Response System (IRS) and the Compensatory Immune-Regulatory Reflex System (CIRS) in Different Phenotypes of Schizophrenia: the IRS-CIRS Theory of Schizophrenia

    Article • Molecular Neurobiology, August 2019, Springer Science + Business Media

    George Anderson

  50. Left Ventricular Hypertrophy: Roles of Mitochondria CYP1B1 and Melatonergic Pathways in Co-Ordinating Wider Pathophysiology

    Article • International Journal of Molecular Sciences, August 2019, MDPI AG

    George Anderson

  51. Endometriosis Pathoetiology and Pathophysiology: Roles of Vitamin A, Estrogen, Immunity, Adipocytes, Gut Microbiome and Melatonergic Pathway on Mitochondria Regulation

    Article • BioMolecular Concepts, July 2019, De Gruyter

    George Anderson

  52. Mitochondria and the Gut as crucial hubs for the interactions of melatonin with sirtuins, inflammation, butyrate, tryptophan metabolites, and alpha 7 nicotinic receptor across a host of medical conditions.

    Article • Melatonin Research, June 2019, ST Bio-life

    George Anderson

  53. Mitochondria: the birth place, battle ground and the site of melatonin metabolism in cells

    Article • Melatonin Research, February 2019, ST Bio-life

    George Anderson

  54. Depression and neuroprogression: Sirtuins and mitochondria as crucial hubs

    Article • February 2019, Oxford University Press (OUP)

    George Anderson

  55. Reframes nature of GBM and GSCs

    Article • International Journal of Tryptophan Research, January 2019, SAGE Publications

    George Anderson

  56. Common Environmental Factors May Underpin the Comorbidity Between Generalized Anxiety Disorder and Mood Disorders Via Activated Nitrooxidative Pathways

    Article • Current Topics in Medicinal Chemistry, December 2018, Bentham Science Publishers

    George Anderson

  57. The neurobiology of adaptation to seasons: Relevance and correlations in bipolar disorders

    Article • Chronobiology International, June 2018, Taylor & Francis

    George Anderson , Dr Pierre Alexis Geoffroy

  58. Lowered quality of life in mood disorders is associated with increased neuro-oxidative stress and basal thyroid-stimulating hormone levels and use of anticonvulsant mood stabilizers

    Article • Journal of Evaluation in Clinical Practice, April 2018, Wiley

    George Anderson

  59. In major affective disorders, early life trauma predict increased nitro-oxidative stress, lipid peroxidation and protein oxidation and recurrence of major affective disorders, suicidal behaviors and a lowered quality of life

    Article • Metabolic Brain Disease, March 2018, Springer Science + Business Media

    George Anderson

  60. Reciprocal Interactions of Mitochondria and the Neuroimmunoendocrine System in Neurodegenerative Disorders: An Important Role for Melatonin Regulation

    Article • Frontiers in Physiology, March 2018, Frontiers

    George Anderson

  61. Bright light and oxygen therapies decrease delirium risk in critically ill surgical patients by targeting sleep and acid-base disturbances

    Article • Psychiatry Research, March 2018, Elsevier

    George Anderson

  62. A neuro-immune, neuro-oxidative and neuro-nitrosative model of prenatal and postpartum depression

    Article • Progress in Neuro-Psychopharmacology and Biological Psychiatry, February 2018, Elsevier

    George Anderson

  63. Associations between severity of anxiety and clinical and biological features of major affective disorders

    Article • Psychiatry Research, February 2018, Elsevier

    George Anderson

  64. Linking the biological underpinnings of depression: Role of mitochondria interactions with melatonin, inflammation, sirtuins, tryptophan catabolites, DNA repair and oxidative and nitrosative stress, with consequences for classification and cognition

    Article • Progress in Neuro-Psychopharmacology and Biological Psychiatry, January 2018, Elsevier

    George Anderson

  65. Depressive, anxiety and hypomanic symptoms in schizophrenia may be driven by tryptophan catabolite (TRYCAT) patterning of IgA and IgM responses directed to TRYCATs

    Article • Progress in Neuro-Psychopharmacology and Biological Psychiatry, January 2018, Elsevier

    George Anderson

  66. Affective symptoms in schizophrenia are strongly associated with neurocognitive deficits indicating disorders in executive functions, visual memory, attention and social cognition

    Article • Progress in Neuro-Psychopharmacology and Biological Psychiatry, January 2018, Elsevier

    George Anderson

  67. The Biological Underpinnings of Mood Disorders Interact With Early Trauma, Sexual Abuse and Neuroticism: Implications for Psychiatric Classification and Treatment

    Article • January 2018, Elsevier

    George Anderson

  68. Changes in Tryptophan Catabolite (TRYCAT) Pathway Patterning Are Associated with Mild Impairments in Declarative Memory in Schizophrenia and Deficits in Semantic and Episodic Memory Coupled with Increased False-Memory Creation in Deficit Schizophrenia

    Article • Molecular Neurobiology, September 2017, Springer Science + Business Media

    George Anderson

  69. Psychosis: glia, immunity, and melatonin

    Article • Brazilian Journal of Psychiatry, September 2017, FapUNIFESP (SciELO)

    George Anderson

  70. Shared metabolic and immune-inflammatory, oxidative and nitrosative stress pathways in the metabolic syndrome and mood disorders

    Article • Progress in Neuro-Psychopharmacology and Biological Psychiatry, August 2017, Elsevier

    George Anderson

  71. Oxidative and Nitrosative Stress, Immune Inflammation and Trptophan Catabolites in Driving Melatonergic Pathway Alterations in Depression: Treatment Implications

    Article • July 2017, Bentham Science Publishers

    George Anderson

  72. IgA/IgM Responses to Gram-Negative Bacteria are not Associated with Perinatal Depression, but with Physio-somatic Symptoms and Activation of the Tryptophan Catabolite Pathway at the End of Term and Postnatal Anxiety

    Article • CNS & Neurological Disorders - Drug Targets, July 2017, Bentham Science Publishers

    George Anderson

  73. IgM-mediated autoimmune responses to oxidative specific epitopes, but not nitrosylated adducts, are significantly decreased in pregnancy: association with bacterial translocation, perinatal and lifetime major depression and the tryptophan catabolite (T...

    Article • Metabolic Brain Disease, June 2017, Springer Science + Business Media

    George Anderson

  74. Increased Root Canal Endotoxin Levels are Associated with Chronic Apical Periodontitis, Increased Oxidative and Nitrosative Stress, Major Depression, Severity of Depression, and a Lowered Quality of Life

    Article • Molecular Neurobiology, April 2017, Springer Science + Business Media

    George Anderson

  75. How Immune-inflammatory Processes Link CNS and Psychiatric Disorders: Classification and Treatment Implications

    Article • CNS & Neurological Disorders - Drug Targets, April 2017, Bentham Science Publishers

    George Anderson

  76. Deficit Schizophrenia Is Characterized by Defects in IgM-Mediated Responses to Tryptophan Catabolites (TRYCATs): a Paradigm Shift Towards Defects in Natural Self-Regulatory Immune Responses Coupled with Mucosa-Derived TRYCAT Pathway Activation

    Article • Molecular Neurobiology, March 2017, Springer Science + Business Media

    George Anderson

  77. Physio-somatic symptoms in schizophrenia: association with depression, anxiety, neurocognitive deficits and the tryptophan catabolite pathway

    Article • Metabolic Brain Disease, March 2017, Springer Science + Business Media

    George Anderson

  78. Deficit, but Not Nondeficit, Schizophrenia Is Characterized by Mucosa-Associated Activation of the Tryptophan Catabolite (TRYCAT) Pathway with Highly Specific Increases in IgA Responses Directed to Picolinic, Xanthurenic, and Quinolinic Acid

    Article • Molecular Neurobiology, February 2017, Springer Science + Business Media

    George Anderson

  79. Breastfeeding and the gut-brain axis: is there a role for melatonin?

    Article • BioMolecular Concepts, January 2017, De Gruyter

    George Anderson

  80. Interactions of Tryptophan and Its Catabolites With Melatonin and the Alpha 7 Nicotinic Receptor in Central Nervous System and Psychiatric Disorders: Role of the Aryl Hydrocarbon Receptor and Direct Mitochondria Regulation

    Article • International Journal of Tryptophan Research, January 2017, SAGE Publications

    George Anderson

  81. Alpha 7 Nicotinic Receptor Agonist Modulatory Interactions with Melatonin: Relevance not only to Cognition, but to Wider Neuropsychiatric and Immune Inflammatory Disorders

    Article • December 2016, Bentham Science Publishers

    George Anderson

  82. Gut Permeability and Microbiota in Parkinson’s Disease: Role of Depression, Tryptophan Catabolites, Oxidative and Nitrosative Stress and Melatonergic Pathways

    Article • Current Pharmaceutical Design, December 2016, Bentham Science Publishers

    George Anderson

  83. Multiple Sclerosis, Gut Microbiota and Permeability: Role of Tryptophan Catabolites, Depression and the Driving Down of Local Melatonin

    Article • Current Pharmaceutical Design, December 2016, Bentham Science Publishers

    George Anderson

  84. Intestinal Dysbiosis, Gut Hyperpermeability and Bacterial Translocation: Missing Links Between Depression, Obesity and Type 2 Diabetes

    Article • Current Pharmaceutical Design, December 2016, Bentham Science Publishers

    George Anderson

  85. A Role for the Regulation of the Melatonergic Pathways in Alzheimer’s Disease and Other Neurodegenerative and Psychiatric Conditions

    Article • November 2016, Taylor & Francis

    George Anderson

  86. Single-Nucleotide Polymorphisms of Genes Involved in Repair of Oxidative DNA Damage and the Risk of Recurrent Depressive Disorder

    Article • Medical Science Monitor, November 2016, International Scientific Literature

    George Anderson

  87. Hypothalamic-Pituitary-Adrenal Hypofunction in Myalgic Encephalomyelitis (ME)/Chronic Fatigue Syndrome (CFS) as a Consequence of Activated Immune-Inflammatory and Oxidative and Nitrosative Pathways

    Article • Molecular Neurobiology, October 2016, Springer Science + Business Media

    George Anderson

  88. Breast Feeding and Melatonin: Implications for Improving Perinatal Health

    Article • Journal of Breastfeeding Biology, July 2016, Open Access Pub

    George Anderson

  89. Direct exposure to N-methyl-d-aspartate alters mitochondrial function

    Article • Neuroscience Letters, June 2016, Elsevier

    George Anderson

  90. T helper 17 cells may drive neuroprogression in major depressive disorder: Proposal of an integrative model

    Article • Neuroscience & Biobehavioral Reviews, May 2016, Elsevier

    Dr Brisa Fernandes, George Anderson

  91. IgA/IgM responses to tryptophan and tryptophan catabolites (TRYCATs) are differently associated with prenatal depression, physio-somatic symptoms at the end of term and premenstrual syndrome

    Article • Molecular Neurobiology, April 2016, Springer Science + Business Media

    George Anderson

  92. Morphofunctional and signaling molecules overlap of the pineal gland and thymus: role and significance in aging

    Article • Oncotarget, March 2016, Impact Journals, LLC

    George Anderson

  93. Bipolar Disorder: The Role of the Kynurenine and Melatonergic Pathways

    Article • Current Pharmaceutical Design, February 2016, Bentham Science Publishers

    George Anderson , Dr Pierre Alexis Geoffroy

  94. Editorial (Thematic Issue: The Kynurenine and Melatonergic Pathways in Psychiatric and CNS Disorders)

    Article • Current Pharmaceutical Design, February 2016, Bentham Science Publishers

    George Anderson

  95. Glioma: Tryptophan Catabolite and Melatoninergic Pathways Link microRNA, 14-3- 3, Chromosome 4q35, Epigenetic Processes and other Glioma Biochemical Changes

    Article • Current Pharmaceutical Design, February 2016, Bentham Science Publishers

    George Anderson

  96. Overlapping the Tryptophan Catabolite (TRYCAT) and Melatoninergic Pathways in Alzheimer';s Disease

    Article • Current Pharmaceutical Design, February 2016, Bentham Science Publishers

    George Anderson

  97. The Many Neuroprogressive Actions of Tryptophan Catabolites (TRYCATs) that may be Associated with the Pathophysiology of Neuro-Immune Disorders

    Article • Current Pharmaceutical Design, February 2016, Bentham Science Publishers

    George Anderson

  98. Incidence of Diabetes in Colorectal Cancer Survivors

    Article • JNCI Journal of the National Cancer Institute, February 2016, Oxford University Press (OUP)

    George Anderson

  99. Melatoninergic Pathways in Alzheimer's Disease

    Article • November 2015, Bentham Science Publishers

    George Anderson

  100. Pharmaceutical and Nutritional Benefits in Alzheimer's Disease via Convergence on the Melatoninergic Pathways

    Article • November 2015, Bentham Science Publishers

    George Anderson

  101. Comorbidity between depression and inflammatory bowel disease explained by immune-inflammatory, oxidative, and nitrosative stress; tryptophan catabolite; and gut–brain pathways

    Article • CNS Spectrums, August 2015, Cambridge University Press

    George Anderson

  102. The Toll-Like Receptor Radical Cycle Pathway: A New Drug Target in Immune-Related Chronic Fatigue

    Article • CNS & Neurological Disorders - Drug Targets, July 2015, Bentham Science Publishers

    George Anderson

  103. The gut–brain axis: The role of melatonin in linking psychiatric, inflammatory and neurodegenerative conditions

    Article • Advances in Integrative Medicine, April 2015, Elsevier

    George Anderson

  104. Multiple sclerosis: The role of melatonin and N-acetylserotonin

    Article • Multiple Sclerosis and Related Disorders, March 2015, Elsevier

    George Anderson

  105. Bipolar Disorder: Role of Immune-Inflammatory Cytokines, Oxidative and Nitrosative Stress and Tryptophan Catabolites

    Article • Current Psychiatry Reports, January 2015, Springer Science + Business Media

    George Anderson

  106. Melatonin (High Dose): A neglected aspect of managing the Ebola virus

    Article • Journal of Medical Virology, January 2015, Wiley

    Professor Regina P Markus, George Anderson

  107. Mechanisms Underlying Neurocognitive Dysfunctions in Recurrent Major Depression

    Article • Medical Science Monitor, January 2015, International Scientific Literature

    George Anderson

  108. Oxidative & nitrosative stress in depression: Why so much stress?

    Article • Neuroscience & Biobehavioral Reviews, September 2014, Elsevier

    George Anderson

  109. Local Melatonin Regulates Inflammation Resolution: A Common Factor in Neurodegenerative, Psychiatric and Systemic Inflammatory Disorders

    Article • CNS & Neurological Disorders - Drug Targets, July 2014, Bentham Science Publishers

    George Anderson

  110. Oxidative/Nitrosative Stress and Immuno-inflammatory Pathways in Depression: Treatment Implications

    Article • Current Pharmaceutical Design, June 2014, Bentham Science Publishers

    George Anderson

  111. The Glutathione System: A New Drug Target in Neuroimmune Disorders

    Article • Molecular Neurobiology, April 2014, Springer Science + Business Media

    George Anderson

  112. Redox Regulation and the Autistic Spectrum: Role of Tryptophan Catabolites, Immuno-inflammation, Autoimmunity and the Amygdala

    Article • Current Neuropharmacology, March 2014, Bentham Science Publishers

    George Anderson

  113. Targeting classical IL-6 signalling or IL-6trans-signalling in depression?

    Article • Expert Opinion on Therapeutic Targets, February 2014, Informa Healthcare

    George Anderson

  114. TRYCAT Pathways Link Peripheral Inflammation, Nicotine, Somatization and Depression in the Etiology and Course of Parkinson’s Disease

    Article • CNS & Neurological Disorders - Drug Targets, February 2014, Bentham Science Publishers

    George Anderson

  115. Reconceptualizing Adult Neurogenesis: Role for Sphingosine-1-Phosphate and Fibroblast Growth Factor-1 in Co-Ordinating Astrocyte-Neuronal Precursor Interactions

    Article • CNS & Neurological Disorders - Drug Targets, February 2014, Bentham Science Publishers

    George Anderson

  116. Increased IL-6 trans-signaling in depression: focus on the tryptophan catabolite pathway, melatonin and neuroprogression

    Article • Pharmacological Reports, November 2013, Elsevier

    George Anderson

  117. Immunolocalization of substance P and NK-1 receptor in hofbauer cells in human normal placenta

    Article • Microscopy Research and Technique, October 2013, Wiley

    George Anderson

  118. Role of Immune-Inflammatory and Oxidative and Nitrosative Stress Pathways in the Etiology of Depression: Therapeutic Implications

    Article • CNS Drugs, October 2013, Springer Science + Business Media

    George Anderson

  119. Melatonin in the Etiology, Pathophysiology, and Management of Schizophrenia

    Article • October 2013, Springer Science + Business Media

    George Anderson

  120. Metabolic Syndrome, Alzheimer Disease, Schizophrenia, and Depression: Role for Leptin, Melatonin, Kynurenine Pathways, and Neuropeptides

    Article • October 2013, Wiley

    George Anderson

  121. Neurodegeneration in Parkinson's Disease: Interactions of Oxidative Stress, Tryptophan Catabolites and Depression with Mitochondria and Sirtuins

    Article • Molecular Neurobiology, October 2013, Springer Science + Business Media

    George Anderson

  122. In myalgic encephalomyelitis/chronic fatigue syndrome, increased autoimmune activity against 5-HT is associated with immuno-inflammatory pathways and bacterial translocation

    Article • Journal of Affective Disorders, September 2013, Elsevier

    George Anderson

  123. Biological phenotypes: somatization, depression, and chronic fatigue syndrome.

    Article • Acta Psychiatrica Scandinavica, August 2013, Wiley

    George Anderson

  124. Increased autoimmune responses against auto-epitopes modified by oxidative and nitrosative damage in depression: Implications for the pathways to chronic depression and neuroprogression

    Article • Journal of Affective Disorders, July 2013, Elsevier

    George Anderson

  125. Coenzyme Q10 Depletion in Medical and Neuropsychiatric Disorders: Potential Repercussions and Therapeutic Implications

    Article • Molecular Neurobiology, June 2013, Springer Science + Business Media

    George Anderson

  126. Comment and reply on: ME is a distinct diagnostic entity, not part of a chronic fatigue spectrum

    Article • Expert Opinion on Medical Diagnostics, May 2013, Informa Healthcare

    Mr Frank NM Twisk, George Anderson

  127. The circadian clock circuitry and the AHR signaling pathway in physiology and pathology

    Article • Biochemical Pharmacology, May 2013, Elsevier

    George Anderson

  128. Prenatal infection important to etiology of schizophrenia

    Article • Progress in Neuro-Psychopharmacology and Biological Psychiatry, April 2013, Elsevier

    George Anderson

  129. Schizophrenia is primed for an increased expression of depression through activation of immuno-inflammatory, oxidative and nitrosative stress, and tryptophan catabolite pathways

    Article • Progress in Neuro-Psychopharmacology and Biological Psychiatry, April 2013, Elsevier

    George Anderson

  130. Immuno-inflammatory, oxidative and nitrosative stress, and neuroprogressive pathways in the etiology, course and treatment of schizophrenia

    Article • Progress in Neuro-Psychopharmacology and Biological Psychiatry, April 2013, Elsevier

    George Anderson

  131. Putative neuroprotective agents in neuropsychiatric disorders

    Article • Progress in Neuro-Psychopharmacology and Biological Psychiatry, April 2013, Elsevier

    George Anderson

  132. A narrative review on the similarities and dissimilarities between myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and sickness behavior

    Article • BMC Medicine, March 2013, Springer Science + Business Media

    George Anderson

  133. Diagnosis of myalgic encephalomyelitis: where are we now?

    Article • Expert Opinion on Medical Diagnostics, February 2013, Informa Healthcare

    George Anderson

  134. Postpartum depression: psychoneuroimmunological underpinnings and treatment

    Article • Neuropsychiatric Disease and Treatment, February 2013, Taylor & Francis

    George Anderson

  135. Identification of an N-Methyl-d-aspartate Receptor in Isolated Nervous System Mitochondria

    Article • Journal of Biological Chemistry, October 2012, Elsevier

    George Anderson

  136. Pro-inflammatory interleukin-18 increases Alzheimer’s disease-associated amyloid-β production in human neuron-like cells

    Article • Journal of Neuroinflammation, August 2012, Springer Science + Business Media

    George Anderson

  137. Hemochromatosis and bipolar disorder

    Article • General Hospital Psychiatry, July 2012, Elsevier

    George Anderson

  138. Depression and sickness behavior are Janus-faced responses to shared inflammatory pathways

    Article • BMC Medicine, June 2012, Springer Science + Business Media

    George Anderson

  139. Biological underpinnings of the commonalities in depression, somatization & Chronic Fatigue Syndrome

    Article • Medical Hypotheses, June 2012, Elsevier

    George Anderson

  140. Melatonin prevents the metabolic dysregulation by anti-psychotics

    Article • Metabolic Brain Disease, April 2012, Springer Science + Business Media

    George Anderson

  141. The Role of Indoleamine 2,3-Dioxygenase in a Mouse Model of Neuroinflammation-Induced Depression

    Article • Journal of Alzheimer’s Disease, February 2012, IOS Press

    George Anderson

  142. Inflammation-Related Disorders in the Tryptophan Catabolite Pathway in Depression and Somatization

    Article • January 2012, Elsevier

    George Anderson

  143. Melatonin and Cognitive Deficits in Bipolar Disorder and Mild Cognitive Impairment

    Article • Psychotherapy and Psychosomatics, January 2012, Karger Publishers

    George Anderson

  144. Multiple sclerosis and seizures: possible role forHelicobacter pylori

    Article • European Journal of Neurology, August 2011, Wiley

    George Anderson

  145. Melatonin, Agomelatine, and Alcoholism

    Article • Addictive Disorders & Their Treatment, June 2011, Wolters Kluwer Health

    George Anderson

  146. Primary role of mitochondrial Rieske iron–sulfur protein in hypoxic ROS production in pulmonary artery myocytes

    Article • Free Radical Biology and Medicine, April 2011, Elsevier

    George Anderson

  147. Amygdala has early postnatal role in regulation of cortex development

    Article • Medical Hypotheses, January 2011, Elsevier

    George Anderson

  148. Hypoxia Induces Intracellular Ca 2+ Release by Causing Reactive Oxygen Species-Mediated Dissociation of FK506-Binding Protein 12.6 from Ryanodine Receptor 2 in Pulmonary Artery Myocytes

    Article • Antioxidants & Redox Signaling, January 2011, SAGE Publications

    George Anderson

  149. Role of IL-18, IDO and melatonin in emergent seizures in MS patients

    Article • European Journal of Neurology, November 2010, Wiley

    George Anderson

  150. Impact of prenatal corticosteroids and modulation by melatonin and vitamin D

    Article • Journal of Pediatric and Adolescent Gynecology, October 2010, Elsevier

    George Anderson

  151. IL-18, IDO and quinolinic acid drive emergent seizures in Alzheimer's disease

    Article • International Journal of Tryptophan Research, January 2010, SAGE Publications

    George Anderson

  152. The role of melatonin in post-partum psychosis and depression associated with bipolar disorder

    Article • Journal of Perinatal Medicine, January 2010, De Gruyter

    George Anderson

  153. Membrane depolarization causes a direct activation of G protein-coupled receptors leading to local Ca 2+ release in smooth muscle

    Article • Proceedings of the National Academy of Sciences, July 2009, Proceedings of the National Academy of Sciences

    George Anderson

  154. Protein Kinase C-ε Regulates Local Calcium Signaling in Airway Smooth Muscle Cells

    Article • American Journal of Respiratory Cell and Molecular Biology, June 2009, Oxford University Press (OUP)

    George Anderson

  155. Hypoxia activates NADPH oxidase to increase [ROS]i and [Ca2+]i through the mitochondrial ROS-PKCɛ signaling axis in pulmonary artery smooth muscle cells

    Article • Free Radical Biology and Medicine, November 2008, Elsevier

    George Anderson

  156. Post-Injury Administration of Mitochondrial Uncouplers Increases Tissue Sparing and Improves Behavioral Outcome following Traumatic Brain Injury in Rodents

    Article • Journal of Neurotrauma, May 2007, SAGE Publications

    George Anderson

  157. Protective Effects of NIM811 in Transient Focal Cerebral Ischemia Suggest Involvement of the Mitochondrial Permeability Transition

    Article • Journal of Neurotrauma, May 2007, SAGE Publications

    George Anderson

  158. The Uncoupling Agent 2,4-Dinitrophenol Improves Mitochondrial Homeostasis following Striatal Quinolinic Acid Injections

    Article • Journal of Neurotrauma, October 2005, SAGE Publications

    George Anderson

  159. The mitochondrial uncoupler 2,4‐dinitrophenol attenuates tissue damage and improves mitochondrial homeostasis following transient focal cerebral ischemia

    Article • Journal of Neurochemistry, August 2005, Wiley

    George Anderson

  160. Mitochondrial uncoupling as a potential therapeutic target in acute central nervous system injury

    Article • Journal of Neurochemistry, September 2004, Wiley

    George Anderson

  161. Some applications of reversal theory to the explanation of gambling and gambling addictions

    Article • Journal of Gambling Behavior, September 1987, Springer Science + Business Media

    George Anderson

  162. First study to show heart rate increase in gamblers and correlated with personality

    Article • British Journal of Psychology, August 1984, Wiley

    George Anderson

  163. Alcohol cues condition changes in arousal

    Article • Psychopharmacology, December 1982, Springer Science + Business Media

    George Anderson